TreeWAS – Variant ID: rs3765535

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z51.0 Radiotherapy session	0.000	0.972	0.028
O82.0 Delivery by elective Caesarean section	0.000	0.980	0.020
O82.1 Delivery by emergency Caesarean section	0.000	0.982	0.018
O82 Single delivery by Caesarean section	0.000	0.982	0.018
O82.9 Delivery by Caesarean section, unspecified	0.000	0.986	0.014
O82.8 Other single delivery by Caesarean section	0.000	0.987	0.013
O82.2 Delivery by Caesarean hysterectomy	0.000	0.987	0.013
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.000	0.987	0.013
R61.9 Hyperhidrosis, unspecified	0.000	0.988	0.012
M25.56 Pain in joint (Lower leg)	0.011	0.989	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.011	0.989	0.000
J45.0 Predominantly allergic asthma	0.010	0.990	0.000
D86 Sarcoidosis	0.010	0.990	0.000
D86.0 Sarcoidosis of lung	0.009	0.991	0.000
D86.8 Sarcoidosis of other and combined sites	0.009	0.991	0.000
D86.9 Sarcoidosis, unspecified	0.009	0.991	0.000
D86.1 Sarcoidosis of lymph nodes	0.008	0.992	0.000
D86.3 Sarcoidosis of skin	0.008	0.992	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.008	0.992	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.008	0.992	0.000
Y45.2 Propionic acid derivatives	0.007	0.993	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.007	0.993	0.000
Y45.1 Salicylates	0.007	0.993	0.000
Y43 Primarily systemic agents	0.007	0.993	0.000
D80-D89 Certain disorders involving the immune mechanism	0.007	0.993	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
Y45.8 Other analgesics and antipyretics	0.007	0.993	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.007	0.993	0.000
Y43.0 Antiallergic and antiemetic drugs	0.006	0.993	0.000
Y95 Nosocomial condition	0.000	0.993	0.006
Y51 Drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
Y48 Anaesthetics and therapeutic gases	0.006	0.994	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.006	0.994	0.000
Y43.4 Immunosuppressive agents	0.006	0.994	0.000
Y45.5 4-Aminophenol derivatives	0.006	0.994	0.000
Y53.4 Other laxatives	0.006	0.994	0.000
Y52 Agents primarily affecting the cardiovascular system	0.006	0.994	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.006	0.994	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.006	0.994	0.000
Y57 Other and unspecified drugs and medicaments	0.006	0.994	0.000
Y43.1 Antineoplastic antimetabolites	0.006	0.994	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.006	0.994	0.000
Y45.4 Antirheumatics	0.006	0.994	0.000
K56.6 Other and unspecified intestinal obstruction	0.000	0.994	0.006
Y59 Other and unspecified vaccines and biological substances	0.006	0.994	0.000
Y58 Bacterial vaccines	0.006	0.994	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.006	0.994	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.006	0.994	0.000
G93.3 Postviral fatigue syndrome	0.006	0.994	0.000
D84 Other immunodeficiencies	0.006	0.994	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
D80 Immunodeficiency with predominantly antibody defects	0.005	0.994	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.006	0.994	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.005	0.994	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.005	0.995	0.000
M06.9 Rheumatoid arthritis, unspecified	0.005	0.995	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
H92.0 Otalgia	0.000	0.995	0.005
Y43.9 Primarily systemic agent, unspecified	0.005	0.995	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.005	0.995	0.000
Y43.6 Enzymes, not elsewhere classified	0.005	0.995	0.000
Y43.5 Acidifying and alkalising agents	0.005	0.995	0.000
Y43.2 Antineoplastic natural products	0.005	0.995	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.005	0.995	0.000
Y48.2 Other and unspecified general anaesthetics	0.005	0.995	0.000
Y40 Systemic antibiotics	0.005	0.995	0.000
Y46.2 Hydantoin derivatives	0.005	0.995	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.005	0.995	0.000
Y57.5 X-ray contrast media	0.005	0.995	0.000
D83 Common variable immunodeficiency	0.005	0.995	0.000
D82 Immunodeficiency associated with other major defects	0.005	0.995	0.000
D81 Combined immunodeficiencies	0.005	0.995	0.000
Y48.3 Local anaesthetics	0.005	0.995	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
Y53.7 Emetics	0.005	0.995	0.000
Y53.6 Antidiarrhoeal drugs	0.005	0.995	0.000
Y53.5 Digestants	0.005	0.995	0.000
Y53.3 Saline and osmotic laxatives	0.005	0.995	0.000
Y53.2 Stimulant laxatives	0.005	0.995	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
Y53.0 Histamine H2-receptor antagonists	0.005	0.995	0.000
W29.9 Unspecified place	0.005	0.995	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.005	0.995	0.000
Y41.5 Antiviral drugs	0.005	0.995	0.000
Y41.4 Anthelminthics	0.005	0.995	0.000
Y41.3 Other antiprotozoal drugs	0.005	0.995	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.005	0.995	0.000
Y41.1 Antimycobacterial drugs	0.005	0.995	0.000
Y41.0 Sulphonamides	0.005	0.995	0.000
Y46.6 Other and unspecified antiepileptics	0.005	0.995	0.000
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
Y45.0 Opioids and related analgesics	0.005	0.995	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
D84.8 Other specified immunodeficiencies	0.005	0.995	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
Y51.0 Anticholinesterase agents	0.005	0.995	0.000
D36 Benign neoplasm of other and unspecified sites	0.005	0.995	0.000
Y48.5 Therapeutic gases	0.005	0.995	0.000
Y48.4 Anaesthetic, unspecified	0.005	0.995	0.000
Y48.1 Parenteral anaesthetics	0.005	0.995	0.000
Y48.0 Inhaled anaesthetics	0.005	0.995	0.000
Y46.8 Antispasticity drugs	0.005	0.995	0.000
Y46.7 Anti-Parkinsonism drugs	0.005	0.995	0.000
Y46.5 Valproic acid	0.005	0.995	0.000
Y46.4 Iminostilbenes	0.005	0.995	0.000
Y46.3 Deoxybarbiturates	0.005	0.995	0.000
Y46.1 Oxazolidinediones	0.005	0.995	0.000
Y46.0 Succinimides	0.005	0.995	0.000
Y54.8 Agents affecting uric acid metabolism	0.005	0.995	0.000
K62.3 Rectal prolapse	0.000	0.995	0.005
D80.1 Nonfamilial hypogammaglobulinaemia	0.005	0.995	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.005	0.995	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.005	0.995	0.000
Y54.3 Benzothiadiazine derivatives	0.004	0.995	0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.001	0.995	0.004
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.995	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.004	0.995	0.000
Y52.7 Peripheral vasodilators	0.004	0.995	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.004	0.995	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.995	0.000
Y40.8 Other systemic antibiotics	0.004	0.995	0.000
Y57.6 Other diagnostic agents	0.004	0.995	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.004	0.995	0.000
Y52.1 Calcium-channel blockers	0.004	0.995	0.000
Y54.9 Mineral salts, not elsewhere classified	0.004	0.995	0.000
Y54.7 Agents affecting calcification	0.004	0.995	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.004	0.995	0.000
Y54.4 Loop [high-ceiling] diuretics	0.004	0.995	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.004	0.995	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.004	0.995	0.000
Y54.0 Mineralocorticoids	0.004	0.995	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.004	0.995	0.000
M19.97 Arthrosis, unspecified (Ankle and foot)	0.000	0.995	0.005
Y57.7 Vitamins, not elsewhere classified	0.004	0.995	0.000
Y57.4 Pharmaceutical excipients	0.004	0.995	0.000
Y57.3 Alcohol deterrents	0.004	0.995	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.004	0.995	0.000
Y57.1 Lipotropic drugs	0.004	0.995	0.000
Y57.0 Appetite depressants [anorectics]	0.004	0.995	0.000
G93.6 Cerebral oedema	0.004	0.996	0.000
R61 Hyperhidrosis	0.000	0.996	0.004
Y42.0 Glucocorticoids and synthetic analogs	0.004	0.996	0.000
Y49.5 Other antipsychotics and neuroleptics	0.004	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.004	0.996	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.004	0.996	0.000
Y47.4 Bromine compounds	0.004	0.996	0.000
Y47.3 Paraldehyde	0.004	0.996	0.000
Y47.2 Chloral derivatives	0.004	0.996	0.000
Y47.1 Benzodiazepines	0.004	0.996	0.000
Y47.0 Barbiturates, not elsewhere classified	0.004	0.996	0.000
Y50.9 Central nervous system stimulant, unspecified	0.004	0.996	0.000
Y50.8 Other central nervous system stimulants	0.004	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.004	0.996	0.000
Y50.1 Opioid receptor antagonists	0.004	0.996	0.000
Y50.0 Analeptics	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
Y55.5 Anticommon cold drugs	0.004	0.996	0.000
Y55.4 Expectorants	0.004	0.996	0.000
Y55.3 Antitussives	0.004	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
Y55.0 Oxytocic drugs	0.004	0.996	0.000
Y58.9 Other and unspecified bacterial vaccines	0.004	0.996	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.004	0.996	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.004	0.996	0.000
Y58.5 Diphtheria vaccine	0.004	0.996	0.000
Y58.4 Tetanus vaccine	0.004	0.996	0.000
Y58.3 Plague vaccine	0.004	0.996	0.000
Y58.2 Cholera vaccine	0.004	0.996	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.004	0.996	0.000
Y58.0 BCG vaccine	0.004	0.996	0.000
Y59.9 Vaccine or biological substance, unspecified	0.004	0.996	0.000
Y59.8 Other specified vaccines and biological substances	0.004	0.996	0.000
Y59.3 Immunoglobulin	0.004	0.996	0.000
Y59.2 Protozoal vaccines	0.004	0.996	0.000
Y59.1 Rickettsial vaccines	0.004	0.996	0.000
Y59.0 Viral vaccines	0.004	0.996	0.000
G93 Other disorders of brain	0.004	0.996	0.000
D84.9 Immunodeficiency, unspecified	0.004	0.996	0.000
O80-O84 Delivery	0.000	0.996	0.004
D84.1 Defects in the complement system	0.004	0.996	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.004	0.996	0.000
Y40.5 Aminoglycosides	0.004	0.996	0.000
Y54.5 Other diuretics	0.004	0.996	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.004	0.996	0.000
Y49.9 Psychotropic drug, unspecified	0.004	0.996	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y49.7 Psychostimulants with abuse potential	0.004	0.996	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.004	0.996	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.004	0.996	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
W29 Contact with other powered hand tools and household machinery	0.004	0.996	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.004	0.996	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.004	0.996	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.004	0.996	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.004	0.996	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.004	0.996	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.004	0.996	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.004	0.996	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.004	0.996	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.004	0.996	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.004	0.996	0.000
D89.3 Immune reconstitution syndrome	0.004	0.996	0.000
D89.1 Cryoglobulinaemia	0.004	0.996	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.004	0.996	0.000
Y57.8 Other drugs and medicaments	0.004	0.996	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.004	0.996	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.004	0.996	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
Y56.9 Topical agent, unspecified	0.004	0.996	0.000
Y56.8 Other topical agents	0.004	0.996	0.000
Y56.7 Dental drugs, topically applied	0.004	0.996	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
Y56.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
Y56.3 Emollients, demulcents and protectants	0.004	0.996	0.000
Y56.2 Local astringents and local detergents	0.004	0.996	0.000
Y56.1 Antipruritics	0.004	0.996	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
Y49.2 Other and unspecified antidepressants	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
Y40.6 Rifamycins	0.004	0.996	0.000
Y40.4 Tetracyclines	0.004	0.996	0.000
Y40.2 Chloramphenicol group	0.004	0.996	0.000
D36.0 Lymph nodes	0.004	0.996	0.000
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
Y91 Evidence of alcohol involvement determined by level of intoxication	0.001	0.996	0.003
D81.9 Combined immunodeficiency, unspecified	0.004	0.996	0.000
D81.8 Other combined immunodeficiencies	0.004	0.996	0.000
D81.7 Major histocompatibility complex class II deficiency	0.004	0.996	0.000
D81.6 Major histocompatibility complex class I deficiency	0.004	0.996	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.004	0.996	0.000
D81.4 Nezelof's syndrome	0.004	0.996	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.004	0.996	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.004	0.996	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.004	0.996	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.004	0.996	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.004	0.996	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.004	0.996	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.004	0.996	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.004	0.996	0.000
D82.2 Immunodeficiency with short-limbed stature	0.004	0.996	0.000
D82.1 Di George's syndrome	0.004	0.996	0.000
D82.0 Wiskott-Aldrich syndrome	0.004	0.996	0.000
D83.9 Common variable immunodeficiency, unspecified	0.004	0.996	0.000
D83.8 Other common variable immunodeficiencies	0.004	0.996	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.004	0.996	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.004	0.996	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.004	0.996	0.000
Y42.5 Other oestrogens and progestogens	0.004	0.996	0.000
Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.6 Natural blood and blood products	0.004	0.996	0.000
Y44.5 Thrombolytic drugs	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.004	0.996	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.004	0.996	0.000
G93.4 Encephalopathy, unspecified	0.004	0.996	0.000
S22.40 Multiple fractures of ribs (closed)	0.004	0.996	0.000
Y42.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
Y42.4 Oral contraceptives	0.004	0.996	0.000
Y42.2 Antithyroid drugs	0.004	0.996	0.000
Y42.1 Thyroid hormones and substitutes	0.004	0.996	0.000
D36.9 Benign neoplasm of unspecified site	0.004	0.996	0.000
G93.5 Compression of brain	0.004	0.996	0.000
W20-W49 Exposure to inanimate mechanical forces	0.004	0.996	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.004	0.996	0.000
D36.7 Other specified sites	0.004	0.996	0.000
Y40.3 Macrolides	0.004	0.996	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.004	0.996	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.996	0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level	0.001	0.996	0.003
Y98 Lifestyle-related condition	0.001	0.996	0.003
Y97 Environmental-pollution-related condition	0.001	0.996	0.003
Y96 Work-related condition	0.001	0.996	0.003
Y91.9 Alcohol involvement, not otherwise specified	0.000	0.996	0.003
R61.1 Generalised hyperhidrosis	0.000	0.997	0.003
U80.0 Penicillin resistant agent	0.003	0.997	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.003	0.997	0.000
G93.9 Disorder of brain, unspecified	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
G93.7 Reye's syndrome	0.003	0.997	0.000
O84 Multiple delivery	0.000	0.997	0.003
O83 Other assisted single delivery	0.000	0.997	0.003
S64.4 Injury of digital nerve of other finger	0.003	0.997	0.000
W29.8 Other specified place	0.003	0.997	0.000
W29.6 Industrial and construction area	0.003	0.997	0.000
W29.0 Home	0.003	0.997	0.000
W29.7 Farm	0.003	0.997	0.000
W29.5 Trade and service area	0.003	0.997	0.000
W29.4 Street and highway	0.003	0.997	0.000
W29.3 Sports and athletics area	0.003	0.997	0.000
W29.2 School, other institution and public administrative area	0.003	0.997	0.000
W29.1 Residential institution	0.003	0.997	0.000
Y43.3 Other antineoplastic drugs	0.003	0.997	0.000
W21 Striking against or struck by sports equipment	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.003	0.997	0.000
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
G93.8 Other specified disorders of brain	0.003	0.997	0.000
R61.0 Localised hyperhidrosis	0.000	0.997	0.003
W27 Contact with nonpowered hand tool	0.003	0.997	0.000
W13.9 Unspecified place	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
Y91.3 Very severe alcohol intoxication	0.001	0.997	0.002
Y91.2 Severe alcohol intoxication	0.001	0.997	0.002
Y91.1 Moderate alcohol intoxication	0.001	0.997	0.002
Y91.0 Mild alcohol intoxication	0.001	0.997	0.002
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.997	0.003
M06 Other rheumatoid arthritis	0.003	0.997	0.000
Y40.0 Penicillins	0.003	0.997	0.000
G93.1 Anoxic brain damage, not elsewhere classified	0.003	0.997	0.000
T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified	0.003	0.997	0.000
S62.61 Fracture of other finger (open)	0.003	0.997	0.000
F17.2 Dependence syndrome	0.000	0.997	0.003
W21.9 Unspecified place	0.003	0.997	0.000
O81 Single delivery by forceps and vacuum extractor	0.000	0.997	0.003
W46 Contact with hypodermic needle	0.003	0.997	0.000
W45 Foreign body or object entering through skin	0.003	0.997	0.000
W43 Exposure to vibration	0.003	0.997	0.000
W42 Exposure to noise	0.003	0.997	0.000
W41 Exposure to high-pressure jet	0.003	0.997	0.000
W40 Explosion of other materials	0.003	0.997	0.000
W39 Discharge of firework	0.003	0.997	0.000
W38 Explosion and rupture of other specified pressurised devices	0.003	0.997	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.003	0.997	0.000
W36 Explosion and rupture of gas cylinder	0.003	0.997	0.000
W35 Explosion and rupture of boiler	0.003	0.997	0.000
W34 Discharge from other and unspecified firearms	0.003	0.997	0.000
W33 Rifle, shotgun and larger firearm discharge	0.003	0.997	0.000
W32 Handgun discharge	0.003	0.997	0.000
W31 Contact with other and unspecified machinery	0.003	0.997	0.000
W30 Contact with agricultural machinery	0.003	0.997	0.000
W28 Contact with powered lawn mower	0.003	0.997	0.000
W26 Contact with knife, sword or dagger	0.003	0.997	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.003	0.997	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.003	0.997	0.000
W20 Struck by thrown, projected or falling object	0.003	0.997	0.000
Chapter XX External causes of morbidity and mortality	0.003	0.997	0.000
S82.60 Fracture of lateral malleolus (closed)	0.000	0.997	0.003
G93.2 Benign intracranial hypertension	0.003	0.997	0.000
G93.0 Cerebral cysts	0.003	0.997	0.000
W49.9 Unspecified place	0.003	0.997	0.000
W07 Fall involving chair	0.003	0.997	0.000
Y90.9 Presence of alcohol in blood, level not specified	0.001	0.997	0.002
Y90.8 Blood alcohol level of 240 mg/100 ml or more	0.001	0.997	0.002
Y90.7 Blood alcohol level of 200-239 mg/100 ml	0.001	0.997	0.002
Y90.6 Blood alcohol level of 120-199 mg/100 ml	0.001	0.997	0.002
Y90.5 Blood alcohol level of 100-119 mg/100 ml	0.001	0.997	0.002
Y90.4 Blood alcohol level of 80-99 mg/100 ml	0.001	0.997	0.002
Y90.3 Blood alcohol level of 60-79 mg/100 ml	0.001	0.997	0.002
Y90.2 Blood alcohol level of 40-59 mg/100 ml	0.001	0.997	0.002
Y90.1 Blood alcohol level of 20-39 mg/100 ml	0.001	0.997	0.002
Y90.0 Blood alcohol level of less than 20 mg/100 ml	0.001	0.997	0.002
W13 Fall from, out of or through building or structure	0.003	0.997	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.003	0.997	0.000
Z99.3 Dependence on wheelchair	0.003	0.997	0.000
W27.6 Industrial and construction area	0.003	0.997	0.000
W07.9 Unspecified place	0.003	0.997	0.000
W22 Striking against or struck by other objects	0.003	0.997	0.000
W44 Foreign body entering into or through eye or natural orifice	0.003	0.997	0.000
S22.4 Multiple fractures of ribs	0.003	0.997	0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.003	0.997	0.000
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.003	0.997	0.000
O83.9 Assisted single delivery, unspecified	0.000	0.997	0.002
O83.8 Other specified assisted single delivery	0.000	0.997	0.002
O83.4 Destructive operation for delivery	0.000	0.997	0.002
O83.3 Delivery of viable foetus in abdominal pregnancy	0.000	0.997	0.002
O83.2 Other manipulation-assisted delivery	0.000	0.997	0.002
O83.1 Other assisted breech delivery	0.000	0.997	0.002
O83.0 Breech extraction	0.000	0.997	0.002
O84.9 Multiple delivery, unspecified	0.000	0.997	0.002
O84.8 Other multiple delivery	0.000	0.997	0.002
O84.2 Multiple delivery, all by Caesarean section	0.000	0.997	0.002
O84.1 Multiple delivery, all by forceps and vacuum extractor	0.000	0.997	0.002
O84.0 Multiple delivery, all spontaneous	0.000	0.997	0.002
W07.0 Home	0.003	0.997	0.000
H92 Otalgia and effusion of ear	0.000	0.997	0.003
W29.09 Contact with other powered hand tools and household machinery; Home; During unspecified activity	0.002	0.997	0.000
W29.62 Contact with other powered hand tools and household machinery; Industrial and construction area ;While working for income	0.002	0.997	0.000
W29.82 Contact with other powered hand tools and household machinery; Other specified places ;While working for income	0.002	0.997	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.003	0.997	0.000
W25 Contact with sharp glass	0.003	0.997	0.000
W00-W19 Falls	0.003	0.997	0.000
V20-V29 Motorcycle rider injured in transport accident	0.003	0.997	0.000
K22.4 Dyskinesia of oesophagus	0.000	0.997	0.003
M06.4 Inflammatory polyarthropathy	0.003	0.997	0.000
W21.3 Sports and athletics area	0.002	0.997	0.000
W21.8 Other specified place	0.002	0.997	0.000
W21.7 Farm	0.002	0.997	0.000
W21.6 Industrial and construction area	0.002	0.997	0.000
W21.5 Trade and service area	0.002	0.997	0.000
W21.4 Street and highway	0.002	0.997	0.000
W21.2 School, other institution and public administrative area	0.002	0.997	0.000
W21.1 Residential institution	0.002	0.997	0.000
W21.0 Home	0.002	0.997	0.000
W49.0 Home	0.002	0.997	0.000
W49.8 Other specified place	0.002	0.997	0.000
W49.7 Farm	0.002	0.997	0.000
W49.6 Industrial and construction area	0.002	0.997	0.000
W49.5 Trade and service area	0.002	0.997	0.000
W49.4 Street and highway	0.002	0.997	0.000
W49.3 Sports and athletics area	0.002	0.997	0.000
W49.2 School, other institution and public administrative area	0.002	0.997	0.000
W49.1 Residential institution	0.002	0.997	0.000
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.003	0.997	0.000
B37.0 Candidal stomatitis	0.003	0.997	0.000
V70-V79 Bus occupant injured in transport accident	0.003	0.997	0.000
Y00-Y09 Assault	0.003	0.997	0.000
W27.9 Unspecified place	0.002	0.997	0.000
W27.0 Home	0.002	0.997	0.000
W27.8 Other specified place	0.002	0.997	0.000
W27.7 Farm	0.002	0.997	0.000
W27.5 Trade and service area	0.002	0.997	0.000
W27.4 Street and highway	0.002	0.997	0.000
W27.3 Sports and athletics area	0.002	0.997	0.000
W27.2 School, other institution and public administrative area	0.002	0.997	0.000
W27.1 Residential institution	0.002	0.997	0.000
M06.3 Rheumatoid nodule	0.002	0.997	0.000
X10-X19 Contact with heat and hot substances	0.002	0.997	0.000
W22.3 Sports and athletics area	0.002	0.997	0.000
W20.8 Other specified place	0.002	0.997	0.000
M06.8 Other specified rheumatoid arthritis	0.002	0.997	0.000
M06.2 Rheumatoid bursitis	0.002	0.997	0.000
M06.1 Adult-onset Still's disease	0.002	0.997	0.000
X50-X57 Overexertion, travel and privation	0.002	0.998	0.000
V01-V09 Pedestrian injured in transport accident	0.002	0.998	0.000
K56.1 Intussusception	0.000	0.998	0.002
N48.8 Other specified disorders of penis	0.002	0.998	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.002	0.998	0.000
W75-W84 Other accidental threats to breathing	0.002	0.998	0.000
M06.37 Rheumatoid nodule (Ankle and foot)	0.002	0.998	0.000
V28 Motorcycle rider injured in noncollision transport accident	0.002	0.998	0.000
O81.5 Delivery by combination of forceps and vacuum extractor	0.000	0.998	0.002
O81.3 Other and unspecified forceps delivery	0.000	0.998	0.002
O81.2 Mid-cavity forceps with rotation	0.000	0.998	0.002
O81.1 Mid-cavity forceps delivery	0.000	0.998	0.002
O81.0 Low forceps delivery	0.000	0.998	0.002
W23.9 Unspecified place	0.002	0.998	0.000
W23.8 Other specified place	0.002	0.998	0.000
W23.6 Industrial and construction area	0.002	0.998	0.000
W23.5 Trade and service area	0.002	0.998	0.000
W23.0 Home	0.002	0.998	0.000
W23.7 Farm	0.002	0.998	0.000
W23.4 Street and highway	0.002	0.998	0.000
W23.3 Sports and athletics area	0.002	0.998	0.000
W23.2 School, other institution and public administrative area	0.002	0.998	0.000
W23.1 Residential institution	0.002	0.998	0.000
W24.8 Other specified place	0.002	0.998	0.000
W24.9 Unspecified place	0.002	0.998	0.000
W24.7 Farm	0.002	0.998	0.000
W24.6 Industrial and construction area	0.002	0.998	0.000
W24.5 Trade and service area	0.002	0.998	0.000
W24.4 Street and highway	0.002	0.998	0.000
W24.3 Sports and athletics area	0.002	0.998	0.000
W24.2 School, other institution and public administrative area	0.002	0.998	0.000
W24.1 Residential institution	0.002	0.998	0.000
W24.0 Home	0.002	0.998	0.000
W26.9 Unspecified place	0.002	0.998	0.000
W26.5 Trade and service area	0.002	0.998	0.000
W26.0 Home	0.002	0.998	0.000
W26.8 Other specified place	0.002	0.998	0.000
W26.7 Farm	0.002	0.998	0.000
W26.6 Industrial and construction area	0.002	0.998	0.000
W26.4 Street and highway	0.002	0.998	0.000
W26.3 Sports and athletics area	0.002	0.998	0.000
W26.2 School, other institution and public administrative area	0.002	0.998	0.000
W26.1 Residential institution	0.002	0.998	0.000
W28.0 Home	0.002	0.998	0.000
W28.9 Unspecified place	0.002	0.998	0.000
W28.8 Other specified place	0.002	0.998	0.000
W28.7 Farm	0.002	0.998	0.000
W28.6 Industrial and construction area	0.002	0.998	0.000
W28.5 Trade and service area	0.002	0.998	0.000
W28.4 Street and highway	0.002	0.998	0.000
W28.3 Sports and athletics area	0.002	0.998	0.000
W28.2 School, other institution and public administrative area	0.002	0.998	0.000
W28.1 Residential institution	0.002	0.998	0.000
W30.9 Unspecified place	0.002	0.998	0.000
W30.8 Other specified place	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations